Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 1,075 · FY2023 1,127 · FY2024 800 — 3-yr total 3,001
Georgian pharmacy/pharma-distribution company under the Vitamini brand.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 62 | 239 | 3,907 | 978 | 5,212 | 2,485 | 658 | +48.3% |
| Net Cash used in Investing Activities | 0 | 0 | 129 | 244 | 279 | 860 | 525 | +42.0% |
| Free Cash Flow (OCF − Capex proxy) | 62 | 239 | 3,778 | 735 | 4,933 | 1,625 | 133 | +13.6% |
| Net Cash from Financing Activities | 0 | 0 | 3,678 | 327 | 3,584 | 1,065 | 553 | -37.7% |
| Net Change in Cash (before FX) | 62 | 239 | 100 | 407 | 1,349 | 560 | 420 | nmf |
| Effect of FX on Cash | 0 | 0 | 0 | 196 | 404 | 71 | 113 | nmf |
| Net Change in Cash (incl. FX) | 62 | 239 | 100 | 211 | 945 | 489 | 533 | nmf |
| Cash at Beginning of Year | 537 | 599 | 360 | 460 | 671 | 1,615 | 2,104 | +25.5% |
| Cash at End of Year | 599 | 360 | 460 | 671 | 1,615 | 2,104 | 1,571 | +17.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).